Publications

  • Grid View
  • List View
2016

Fingolimod Versus Teiflunomide: Characteristics of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis and Taking Oral Disease Modifying Therapies

Download Publication
2016

Comparison of Characteristics of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis and Taking Subcutaneously Administered Disease Modifying Therapies: Interferon Beta 1b Versus 1a

Download Publication
2016

Health Economic Evaluation of Orally Versus Subcutaneously Administered Disease Modifying Therapies for Patients Diagnosed With Relapsing Remitting Multiple Sclerosis

Download Publication
2016

Fingolimod Versus Teiflunomide: Health Care Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Therapies in the United States

Download Publication
2016

Health Economic Evaluation of Interferon Beta 1b Versus 1a for Patients Diagnosed With Relapsing Remitting Multiple Sclerosis

Download Publication
2016

Orals Versus Subcutaneous Administration of Disease Modifying Therapies: A Comparison of Characteristics of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis

Download Publication
2016

Graphical Analysis of Treatment Patterns among Patients with Pancreatic Neuroendocrine Tumors Newly Treated with Cytotoxic Chemotherapy or Targeted Therapy

Download Publication
2016

Budget Impact of Somatostatin Analogs (SSAs) as Treatment for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (mGEP-NETs) in United States Hospitals

Download Publication
2016

Mortality, Costs, and Length of Stay in Patients with Idiopathic Pulmonary Fibrosis

Download Publication